Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pethidine (also known as meperidine and as
Demerol
) injected subcutaneously at 10 mg/kg into parturient rats on the birth of the second pup resulted in a marked slowing of the progress of parturition, associated with reduced plasma
oxytocin
concentrations. Injection of the opiate antagonist naloxone counteracted the inhibition of
oxytocin
secretion and largely prevented the slowing of parturition. In vitro, pethidine inhibited spontaneous,
oxytocin
-induced and acetylcholine-induced contractions of uteri from rats immediately post partum, and these effects were not reversed by naloxone. In anesthetized lactating rats, pethidine inhibited the suckling-induced milk-ejection reflex and attenuated
oxytocin
-induced contractions of mammary myoepithelium. Finally, pethidine depressed plasma
oxytocin
concentrations in rats given 2% saline to drink for 24 h to stimulate
oxytocin
secretion. Thus pethidine inhibits
oxytocin
secretion in all three conditions; this inhibition is probably mediated by central opioid receptors. In addition, however, pethidine depresses the
oxytocin
responsiveness both of mammary myoepithelium and of myometrium. The latter effect at least is not opioid mediated.
...
PMID:Pethidine (meperidine) inhibition of oxytocin secretion and action in parturient rats. 187 95